Insider · CIK 0001995131
Robert Keith Woods
Files at NGNE (Neurogene Inc.). First filing -, latest -.
Robert Keith Woods files SEC Form 4 as director at NGNE (Neurogene Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Robert Keith Woods has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | NGNE Neurogene Inc. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +12,050 | $0.00 | $0 | 12,050 | Jun 13, 2025 |
Questions about Robert Keith Woods
Answered from the filings on this page, as of the latest one.
Is Robert Keith Woods buying or selling?
Robert Keith Woods has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Robert Keith Woods's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert Keith Woods has 0.
Where does Robert Keith Woods file Form 4?
Robert Keith Woods has filed Form 4 at NGNE (Neurogene Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.